Erratum: The risk of incident type 2 diabetes in a korean metabolically healthy obese population: The role of systemic inflammation (Journal of Clinical Endocrinology and Metabolism (2015) 100 (934-941) DOI: 10.1210/jc.2014-3885);The risk of incident type 2 diabetes in a Korean metabolically healthy obese population: The role of systemic inflammation

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 3, 2015, Pages 934-941

  Jung, Chang Hee ^a   Lee, Min Jung ^a   Kang, Yu Mi ^a   Jang, Jung Eun ^a   Leem, Jaechan ^a   Hwang, Jenie Yoonoo ^a   Kim, Eun Hee ^a   Park, Joong Yeol ^a   Kim, Hong Kyu ^a   Lee, Woo Je ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE FREE SURVIVAL; DRINKING BEHAVIOR; FAMILY HISTORY; FEMALE; HUMAN; INCIDENCE; INFLAMMATION; LABORATORY TEST; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING HABIT; SOUTH KOREAN; SURVIVAL TIME; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; COMPLICATION; DIABETES MELLITUS, TYPE 2; HEALTH; METABOLISM; MIDDLE AGED; RISK; SOUTH KOREA; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH; HUMANS; INCIDENCE; INFLAMMATION; MALE; MIDDLE AGED; OBESITY; REPUBLIC OF KOREA; RISK; YOUNG ADULT;

EID: 84925002678     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-1676     Document Type: Erratum

References (39)

1. Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond). 2008;32:1431-1437.
2. Phillips CM. Metabolically healthy obesity: Definitions, determinants and clinical implications. Rev Endocr Metab Disord. 2013;14:219-227.
3. Primeau V, Coderre L, Karelis AD, et al. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond). 2011;35:971-981.
4. Ruderman NB, Schneider SH, Berchtold P. The "metabolically-obese," normal-weight individual. Am J Clin Nutr. 1981;34:1617-1621.
5. Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis. Ann Intern Med. 2013;159:758-769.
6. Hinnouho GM, Czernichow S, Dugravot A, Batty GD, Kivimaki M, Singh-Manoux A. Metabolically healthy obesity and risk of mortality: Does the definition of metabolic health matter? Diabetes Care. 2013;36:2294-2300.
7. Twig G, Afek A, Derazne E, et al. diabetes risk among overweight and obese metabolically healthy young adults. Diabetes Care. 2014;37(11):2989-2995.
8. Hinnouho GM, Czernichow S, Dugravot A, et al. Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: The Whitehall II cohort study. Eur Heart J. 2014. http://eurheartj.oxfordjournals.org/content/early/2014/03/25/eurheartj.ehu123.long. Accessed January 14, 2015.
9. Aung K, Lorenzo C, Hinojosa MA, Haffner SM. Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals. J Clin Endocrinol Metab. 2014;99:462-468.
10. Appleton SL, Seaborn CJ, Visvanathan R, et al. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: A cohort study. Diabetes Care. 2013;36:2388-2394.
11. Meigs JB, Wilson PW, Fox CS, et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab. 2006;91:2906-2912.
12. Bluher M. Mechanisms in endocrinology: Are metabolically healthy obese individuals really healthy? Eur J Endocrinol. 2014. http://eje-online.org/content/171/6/R209.long. Accessed January 14, 2015.
13. Esser N, L'Homme L, De Roover A, et al. Obesity phenotype is related to NLRP3 inflammasome activity and immunological profile of visceral adipose tissue. Diabetologia. 2013;56:2487-2497.
14. Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011;11:98-107.
15. Phillips CM, Perry IJ. Does inflammation determine metabolic health status in obese and nonobese adults? J Clin Endocrinol Metab. 2013;98:E1610-E1619.
16. Karelis AD, Faraj M, Bastard JP, et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab. 2005;90:4145-4150.
17. Gómez-Ambrosi J, Catalán V, Rodríguez A, et al. Increased cardiometabolic risk factors and inflammation in adipose tissue in obese subjects classified as metabolically healthy. Diabetes Care. 2014;37:2813-2821.
18. Wildman RP, Kaplan R, Manson JE, et al. Body size phenotypes and inflammation in the Women's Health Initiative Observational Study. Obesity (Silver Spring). 2011;19:1482-1491.
19. Yeh ET, Willerson JT. Coming of age of C-reactive protein: Using inflammation markers in cardiology. Circulation. 2003;107:370-371.
20. Jung CH, Lee MJ, Hwang JY, et al. Association of metabolically healthy obesity (MHO) with subclinical coronary atherosclerosis in a Korean population. Obesity (Silver Spring). 2014;22:2613-2620.
21. American Diabetes Association. Standards of medical care in diabetes - 2013. Diabetes Care. 2013;36:S11-SS66.
22. Furusyo N, Koga T, Ai M, et al. Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: Results from the Kyushu and Okinawa Population Study (KOPS). Diabetologia. 2011;54:3028-3036.
23. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157-163.
24. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
25. Alpert JS. "So, doctor, what's so bad about being fat?" Combating the obesity epidemic in the United States. AmJ Med. 2010;123:1-2.
26. Wildman RP, Muntner P, Reynolds K, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: Prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med. 2008;168:1617-1624.
27. Badoud F, Lam KP, DiBattista A, et al. Serum and adipose tissue amino acid homeostasis in the metabolically healthy obese. J Proteome Res. 2014;13:3455-3466.
28. Solinas G, Vilcu C, Neels JG, et al. JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab. 2007;6:386-397.
29. Lemieux I, Pascot A, Prud'homme D, et al. Elevated C-reactive protein: Another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol. 2001;21:961-967.
30. Tan KC, Wat NM, Tam SC, Janus ED, Lam TH, Lam KS. C-reactive protein predicts the deterioration of glycemia in chinese subjects with impaired glucose tolerance. Diabetes Care. 2003;26:2323-2328.
31. Barzilay JI, Abraham L, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: The Cardiovascular Health Study. Diabetes. 2001;50:2384-2389.
32. Arnlöv J, Sundström J, Ingelsson E, Lind L. Impact of BMI and the metabolic syndrome on the risk of diabetes in middle-aged men. Diabetes Care. 2011;34:61-65.
33. Bell JA, Kivimaki M, Hamer M. Metabolically healthy obesity and risk of incident type 2 diabetes: A meta-analysis of prospective cohort studies. Obes Rev. 2014;15:504-515.
34. Yoon KH, Lee JH, Kim JW, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet. 2006;368:1681-1688.
35. Razak F, Anand SS, Shannon H, et al. Defining obesity cut points in a multiethnic population. Circulation. 2007;115:2111-2118.
36. Hwang LC, Bai CH, Sun CA, Chen CJ. Prevalence of metabolically healthy obesity and its impacts on incidences of hypertension, diabetes and the metabolic syndrome in Taiwan. Asia Pac J Clin Nutr. 2012;21:227-233.
37. Jung HS, Chang Y, Eun Yun K, et al. Impact of body mass index, metabolic health and weight change on incident diabetes in a Korean population. Obesity (Silver Spring). 2014;22:1880-1887.
38. Rhee EJ, Lee MK, Kim JD, et al. Metabolic health is a more important determinant for diabetes development than simple obesity: A 4-year retrospective longitudinal study. PLoS One. 2014;9:e98369.
39. Velho S, Paccaud F, Waeber G, Vollenweider P, Marques-Vidal P. Metabolically healthy obesity: Different prevalences using different criteria. Eur J Clin Nutr. 2010;64:1043-1051.